Effect of OM-85 BV on Wheezing Related Morbidity in Children With Recurrent Wheezing

• Status: Completed
• Trial end date: 2008-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether OM-85 BV (Broncho-Vaxom)has any effect on respiratory infections, infection related wheezing attacks, beta-2 agonist use, duration of attacks and effect on serum cytokine levels.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kecioren Education and Training Hospital
• Treatments: Broncho-Vaxom

Criteria

Inclusion Criteria:

• Children with recurrent wheezing who had at least 3 wheezing attacks in the last 6 months

• Children with asthma who had at least 3 wheezing attacks in the last 6 months

Exclusion Criteria:

• Chronic lung disease

• Immun deficiency

• Malabsorption

• Anatomic abnormalities of the respiratory tract

• Gastroesophageal reflux disease